Meeting Details
- Date: Friday, August 14, 2026
- Location: Corporate office of the Company
Agenda Items
1. Consideration and approval of the Un-Audited Financial Results of the Company for the first quarter ended on June 30, 2026
2. Evaluation of fundraising through issue of equity shares and/or any other eligible securities, including but not limited to warrants, or any combination thereof or securities representing equity shares or convertible into or exchangeable for equity shares
3. Any other Business with the permission of chair and majority of directors
Fundraising Considerations
The Board will evaluate fundraising through:
- Preferential issue
- Rights issue
- Other permissible modes or combination thereof
Any fundraising would be subject to necessary approvals.
Trading Window Closure
In accordance with the Company's Code of Conduct for Prevention of Insider Trading:
- Trading Window for trading in the Company's equity shares has been closed from July 1, 2026
- Closure period will continue until expiry of 48 hours from the date the Results are declared and made public
- Trading Window Closure Period will end 48 hours after the Results are declared and made public on Friday, August 14, 2026